Abstract
BackgroundAlthough endovascular coiling has become a standard of care for treatment of intracranial aneurysms, up to 30% of treated aneurysms will recur. Using mesenchymal stem cells (MSCs) as an adjunctive...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
